Supo-Escalante, R.R.; Médico, A.; Gushiken, E.; Olivos-Ramírez, G.E.; Quispe, Y.; Torres, Fiorella; Zamudio, M.; Antiparra, R.; Mario Amzel, L.; Gilman, Robert Hugh; Sheen Cortavarria, Patricia; Zimic-Peralta, Mirko Juan
(Public Library of Science, 2020)
Background: Pyrazinamide is an important drug against the latent stage of tuberculosis and is used in both first- and second-line treatment regimens. Pyrazinamide-susceptibility test usually takes a week to have a diagnosis ...
